Skip to main content
SpringerLink
Log in
Book cover

Hematopathology pp 79–102Cite as

Using Cytogenetic and Molecular Tests in Diagnostic Workups with the WHO Classification – 2008

  • Chapter
  • First Online:

  • 1325 Accesses

Part of the book series: Molecular and Translational Medicine ((MOLEMED))

Abstract

A critical review of the neoplastic disorders of hematopoietic cells has been conducted by panels of expert clinicians and pathologists under the sponsorship of the World Health Organization (WHO), and from this effort a comprehensive classification for these disorders has been developed. Clinical features, phenotypic characteristics of the cellular proliferations, and, in many instances, genotypic features of the abnormal cells are all used in characterizing these disorders. Detailed descriptions and discussions of diagnostically important features for the entities defined within this classification have been summarized and published in a monograph – WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues [1] – which represents the consensus of the many experts who have contributed to the WHO project.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Swerdlow SH, Campo E, Harris NL, Jatte ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO Tumours of Haematopoietic and Lymphoid Tissues. International Agency for research on Cancer. Lyon, France: IARC; 2008. pp. 439.

    Google Scholar 

  2. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood. 2008;112:4384–4399.

    Article  PubMed  CAS  Google Scholar 

  3. Dunphy CH. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. Arch Pathol Lab Med. 2004;128:1004–1022.

    PubMed  Google Scholar 

  4. Arber DA. Review: molecular diagnostic approach to non-Hodgkin’s lymphoma. J Mol Diagn. 2000;2:178–190.

    Article  PubMed  CAS  Google Scholar 

  5. Bench AJ, Erber WN, Scott MA. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders. Clin Lab Haem. 2005;27:148–171.

    Article  CAS  Google Scholar 

  6. Bench AJ, Erber WN, Follows GA, Scott MA. Molecular genetic analysis of haematological malignancies II: mature lymphoid neoplasms. Int J Lab Hem. 2007;29:229–260.

    Article  CAS  Google Scholar 

  7. Garcia F MD, Swerdlow SH. Best practices in contemporary diagnostic immunohistochemistry panel approach to hematolymphoid proliferations. Arch Pathol Lab Med. 2009;133:756–765.

    PubMed  Google Scholar 

  8. Wolff DJ, Bagg A, Cooley LD, et al. Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007;9:134–143.

    Article  PubMed  CAS  Google Scholar 

  9. Ventura RA, Martin-Subero JI, Jones M, et al. Review: FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8:141–151.

    Article  PubMed  CAS  Google Scholar 

  10. van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing. Leukemia. 2007;21:201–206.

    Article  PubMed  Google Scholar 

  11. van der Velden VHJ, Hochhaus A, Cazzaniga G, et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia. 2003;17:1013–1034.

    Article  PubMed  Google Scholar 

  12. Bejjani BA, Shaffer LG. Review: application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn. 2006;8:528–533.

    Article  PubMed  CAS  Google Scholar 

  13. Dunphy CH. Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications. Arch Pathol Lab Med. 2006;130:483–520.

    PubMed  CAS  Google Scholar 

  14. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951.

    Article  PubMed  CAS  Google Scholar 

  15. Hughes T, Deininger M, Hochhaus A, et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood. 2006;108:28–37.

    Article  PubMed  CAS  Google Scholar 

  16. Tefferi A, Gilliland G. The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. Mayo Clin Proc. 2005;80:947–958.

    Article  PubMed  CAS  Google Scholar 

  17. Lay M, Mariappan R, Gotlib J, et al. Detection of the JAK2 V617F mutation by LightCycler PCR and Probe Dissociation Analysis. J Mol Diagn. 2006;8:330–334.

    Article  PubMed  CAS  Google Scholar 

  18. Arber DA, Stein AS, Carter NH, et al. Prognostic impact of acute myeloid leukemia classification: importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Am J Clin Pathol. 2003;119:672–680.

    Article  PubMed  Google Scholar 

  19. van der Reijden BA, Simons A, Luiten E, et al. Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion. Acute myeloid leukaemia. Br J Haematol. 2002;118:411–418.

    Article  PubMed  Google Scholar 

  20. Iijima T, Inadome Y, Noguch Mi. Clonal proliferation of b lymphocytes in the germinal centers of human reactive lymph nodes: possibility of overdiagnosis of b cell clonal proliferation. Diagn Mol Pathol. 2000;9:132–136.

    Article  PubMed  CAS  Google Scholar 

  21. Nam-Cha SH, San-Milla´n B, Mollejo M, et al. Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases. Histopathology. 2008;52:436–444.

    Article  PubMed  CAS  Google Scholar 

  22. Dippel E, Klemke CD, Hummel M, et al. T-cell clonality of undetermined significance. Blood. 2001;98:247–248.

    Article  PubMed  CAS  Google Scholar 

  23. Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of ‘indolent’ chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635–639.

    Article  PubMed  CAS  Google Scholar 

  24. Dong L, Masaki Y, Takegami T, et al. Clonality analysis of lymphoproliferative disorders in patients with Sjogren’s syndrome. Clin Exp Immunol. 2007;150:279–284.

    Article  PubMed  CAS  Google Scholar 

  25. Zhou XG, Sandvej K, Gregersen N, et al. Detection of clonal B cells in microdissected reactive lymphoproliferations: possible diagnostic pitfalls in PCR analysis of immunoglobulin heavy chain gene rearrangement. J Clin Pathol. 1999;52:104–110.

    Article  CAS  Google Scholar 

  26. Elenitoba-Johnson KS, Bohling SD, Mitchell RS, et al. PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn. 2000;2:92–96.

    Article  PubMed  CAS  Google Scholar 

  27. Langerak AW, Molina TJ, Lavender FL, et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2007;21:222–229.

    Article  PubMed  CAS  Google Scholar 

  28. Murphy KM, Berg KD, Geiger T, et al. Consultations in molecular diagnostics: capillary electrophoresis artifact due to eosin: implications for the interpretation of molecular diagnostic assays. J Mol Diagn. 2005;7:143–148.

    Article  PubMed  CAS  Google Scholar 

  29. Kojo S, Elenitoba-Johnson J, Bohling SD, et al. PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn. 2000;2:92–96.

    Article  Google Scholar 

  30. Ahrens K, Braylan R, Almasri N, et al. IgH PCR of zinc formalin-fixed, paraffin-embedded non-lymphomatous gastric samples produces artifactual “Clonal” bands not observed in paired tissues unexposed to zinc formalin. J Mol Diagn. 2002;4:159–163.

    Article  PubMed  CAS  Google Scholar 

  31. Bagg A. Commentary: immunoglobulin and t-cell receptor gene rearrangements: minding your B’s and T’s in assessing lineage and clonality in neoplastic lymphoproliferative disorders. J Mol Diagn. 2006;8:426–429.

    Article  PubMed  CAS  Google Scholar 

  32. Gulley ML, Braziel RM, Halling KC, et al. Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med. 2007;131:852–863.

    PubMed  CAS  Google Scholar 

  33. Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995;85:2528–2536.

    PubMed  CAS  Google Scholar 

  34. Summers KE, Goff LK, Wilson AG, et al. Frequency of the Bcl-2/IGH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol. 2001;19:420–424.

    PubMed  CAS  Google Scholar 

  35. Wohlschlaeger C, Lange K, Merz H, et al. Aberrant immunophenotypes of mantle cell lymphomas. Leuk Lymphoma. 2003;44:269–273.

    Article  PubMed  Google Scholar 

  36. Rao DS, Said JW. Small lymphoid proliferations in extranodal locations. Arch Pathol Lab Med. 2007;131:383–396.

    PubMed  Google Scholar 

  37. Hummel M, Oeschger S, Barth TF, et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut. 2006;55:782–787.

    Article  PubMed  CAS  Google Scholar 

  38. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511.

    Article  PubMed  CAS  Google Scholar 

  39. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350:1828–1837.

    Article  PubMed  CAS  Google Scholar 

  40. Haralambieva E, Boerma E-J, van Imhoff GW, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol. 2005;29:1086–1094.

    PubMed  Google Scholar 

  41. Kuehl WM, Bergsagel PL. Early genetic events provide the basis for a clinical classification of multiple myeloma. Am Soc Hematology. 2005;346–352.

    Google Scholar 

  42. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002;117:368–379.

    Article  PubMed  Google Scholar 

  43. Luzzatto F, Pruneri G, Benini E, et al. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres and a high content of EBV-infected large B-cells carrying IgH chain gene monoclonal rearrangement. Histopathology. 2005;46:464–466.

    Article  PubMed  CAS  Google Scholar 

  44. Tan BT, Warnke RA, Arber DA. The frequency of B and T cell gene rearrangements and EBV in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with and without associated B cell proliferations. J Mol Diagn. 2006;8:466–475.

    Article  PubMed  CAS  Google Scholar 

  45. Lim SH, Badros A, Lue C, et al. Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma. Cancer. 2001;91:900–8.

    Article  PubMed  CAS  Google Scholar 

  46. Sze DM. Clonality detection of expanded T-cell populations in patients with multiple myeloma. Methods Mol Med. 2005;113:257–267.

    PubMed  CAS  Google Scholar 

  47. Gulley ML, Tang W. Review: laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn. 2008;10:279–292.

    Article  PubMed  Google Scholar 

  48. Poppema S, Kluiver JL, Atayar C, et al. Report: workshop on mediastinal grey zone lymphoma. Eur J Haematol. 2005;75(Suppl 66):45–52.

    Article  Google Scholar 

  49. Stein H, Jöhrens K, Anagnostopoulos I. Non-mediastinal grey zone lymphomas and report from the workshop. Eur J Haematol. 2005;75(Suppl 66):42–44.

    Article  Google Scholar 

  50. Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large b-cell lymphoma. Am J Surg Pathol. 2005;29:1411–1421.

    Article  PubMed  Google Scholar 

  51. Ogino S, Gulley ML, den Dunnen JT, et al. Standard mutation nomenclature in molecular diagnostics practical and educational challenges. J Mol Diagn. 2007;9:1–6.

    Article  PubMed  CAS  Google Scholar 

  52. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871–3879.

    Article  PubMed  CAS  Google Scholar 

  53. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt’s lymphoma. N Engl J Med. 2006;354:2431–2442.

    Article  PubMed  CAS  Google Scholar 

  54. Hummel M, Bentink S, Berger H, et al. A Biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419–2430.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA

    Clarence C. Whitcomb

Authors
  1. Clarence C. Whitcomb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clarence C. Whitcomb .

Editor information

Editors and Affiliations

  1. , Department of Clinical Pathology, William Beaumont Hospital, West 13 Mile Road 3601, Royal Oak, 48073-6769, USA

    Domnita Crisan

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Humana Press

About this chapter

Cite this chapter

Whitcomb, C.C. (2011). Using Cytogenetic and Molecular Tests in Diagnostic Workups with the WHO Classification – 2008. In: Crisan, D. (eds) Hematopathology. Molecular and Translational Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-262-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-262-9_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-261-2

  • Online ISBN: 978-1-60761-262-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation